Bone cancer in dogs has a strong hereditary component, especially in large and giant breeds. In Irish Wolfhounds, an estimated 65% of the variation in osteosarcoma risk is explained by genetics, making it one of the most heritable cancers studied in dogs. But heredity isn’t the whole picture. Body size, diet, hormonal timing, and other environmental factors also play a role, which means even dogs with a genetic predisposition aren’t guaranteed to develop the disease.
How Genetics Drive Bone Cancer Risk
Osteosarcoma, the most common bone cancer in dogs, is a complex genetic trait. That means no single gene flips a switch to cause it. Instead, multiple regions across the genome each contribute a piece of the overall risk. A large genome-wide study across Rottweilers, Greyhounds, and Irish Wolfhounds identified 33 inherited risk loci, and together these genetic regions explained between 55% and 85% of the variation in whether a dog developed osteosarcoma within each breed.
One region stands out consistently. A stretch of DNA on canine chromosome 11, home to genes called CDKN2A and CDKN2B, has emerged as the single strongest genetic risk factor. These genes normally help control cell growth. When their function is disrupted, cells can divide unchecked, a hallmark of cancer. This same chromosomal region has shown up in studies of Greyhounds, Leonbergers, and other high-risk breeds, suggesting it’s a shared vulnerability across the species rather than something unique to one bloodline.
Research in Leonbergers pinpointed additional suggestive risk regions on three other chromosomes, though each contributed a smaller share of genetic risk (roughly 1% to 4% individually). The genetics of osteosarcoma, in other words, involve many small contributions layered on top of one or two major ones. Earlier work using a four-generation pedigree of Scottish Deerhounds also traced a risk locus to chromosome 34, reinforcing that these predispositions run in family lines.
Breeds With the Highest Risk
Size is the single most visible risk factor. Osteosarcoma overwhelmingly affects large and giant breeds, and research has shown that a dog’s height at the shoulder is a stronger predictor than body weight alone. The taller the dog, the greater the mechanical and biological stress on its long bones, and the higher the cancer risk.
Rottweilers carry an osteosarcoma prevalence of roughly 1.14%, compared to just 0.03% in mixed-breed dogs. Irish Wolfhounds and Scottish Deerhounds are also well-documented high-risk breeds, though their smaller population numbers sometimes exclude them from large statistical analyses. Greyhounds, Great Danes, Saint Bernards, and Doberman Pinschers round out the list of breeds where osteosarcoma appears far more often than average. The typical age of diagnosis is around seven years, though a small subset of dogs develop it as young adolescents.
Small breeds are not immune, but their risk is dramatically lower. The combination of shorter limb bones and different growth dynamics appears to be genuinely protective.
Environmental Factors That Interact With Genetics
That 65% heritability figure in Irish Wolfhounds leaves roughly 35% of the risk influenced by environmental and lifestyle factors. Several of these are now well studied.
Diet and Caloric Intake
A landmark 15-year study followed 48 Labrador Retrievers from birth to death. Half were fed as much as they wanted, while the other half received 75% of that caloric intake. By 13.5 years into the study, every dog in the unrestricted group had died. A quarter of the calorie-restricted dogs were still alive. The restricted group also experienced significantly delayed cancer development and fewer age-related diseases overall. The takeaway is straightforward: maintaining a lean body condition throughout a dog’s life can meaningfully delay cancer onset, even in breeds with genetic predispositions.
Spaying and Neutering Timing
When a dog is sterilized affects its cancer risk, particularly in larger breeds. Removing the gonads before a dog reaches skeletal maturity disrupts the hormonal signals that close the long-bone growth plates. The bones grow slightly longer than they otherwise would, which may alter joint alignment and increase the biological stress on limb bones. In Golden Retrievers, males neutered before six months had cancer rates of 19%, compared to lower rates in intact dogs. For Irish Wolfhound males neutered at one year, cancer occurrence rose to 25%. These figures cover a combined cancer group that includes osteosarcoma. Small breeds don’t appear to carry the same vulnerability to early neutering.
What Genetic Testing Can and Can’t Tell You
There is no commercially available DNA test that predicts whether your specific dog will develop osteosarcoma based on its inherited risk loci. The 33 risk regions identified in research studies remain tools for population-level understanding rather than individual screening. Breed-specific panels offered by some companies may flag general cancer predisposition, but they can’t give you a yes-or-no answer about bone cancer.
What does exist is a different category of test: liquid biopsy screening that detects cancer signals already circulating in the blood. One such test, OncoK9, screens for 30 types of canine cancer using a blood draw. For the three most aggressive cancers it targets (lymphoma, hemangiosarcoma, and osteosarcoma), the detection rate is 85.4%. This type of test doesn’t identify inherited risk. Instead, it catches cancer that has already begun, potentially before symptoms appear. If you have a high-risk breed, asking your veterinarian about periodic blood-based screening after age five or six is a reasonable conversation to have.
What Osteosarcoma Looks Like
Osteosarcoma typically develops in the long bones of the legs, though it can appear in the jaw, spine, or ribs. The first sign most owners notice is lameness, often sudden and worsening over days to weeks. Swelling at the tumor site follows. Some dogs stop bearing weight on the affected leg entirely. Because this cancer is aggressive, it frequently spreads to the lungs early in the disease, sometimes before the primary tumor is even diagnosed.
When surgery (usually amputation of the affected limb) is combined with chemotherapy, the median survival time is about nine months. With amputation alone, it drops to four months. Individual dogs vary considerably in their response. Follow-up typically involves chest X-rays every two to three months to monitor for lung spread. These are difficult numbers, but knowing them helps you have realistic conversations with your vet about treatment goals and your dog’s quality of life.
Reducing Risk in Predisposed Breeds
You can’t change your dog’s DNA, but you can influence the environmental side of the equation. Keeping your dog at a healthy weight throughout its life is the single most evidence-backed lifestyle intervention. For large and giant breeds, discussing the timing of spaying or neutering with your vet is worthwhile, since delaying sterilization until after skeletal maturity may reduce risk. Avoiding rapid growth in puppyhood through appropriate (not excessive) nutrition is another practical step, as rapid bone growth in large breeds has been linked to skeletal problems.
If you’re choosing a puppy from a high-risk breed, asking the breeder about cancer history in the dog’s lineage is reasonable. Because osteosarcoma is so heritable, breeders who track health outcomes across generations and avoid breeding dogs from heavily affected lines can meaningfully reduce risk over time. Responsible breeding programs in Irish Wolfhounds and Scottish Deerhounds have already begun incorporating this kind of health data into their decisions.